8:20 AM
Mar 26, 2019
 |  BC Extra  |  Politics & Policy

DOJ supports ruling to strike down ACA, including biosimilars provisions

The FDA's biosimilar pathway would be swept away if the Trump administration's decision to back a court ruling results in striking down the entirety of the Affordable Care Act.

In a letter to the U.S. Court of Appeals for the Fifth Circuit Monday, the U.S. Department of Justice said the court should affirm a December district court...

Read the full 264 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >